MJR-35 phase 3 study to investigate the efficacy and safety in patients with adenomyosis (a multicenter, randomized, double-blind, placebo-controlled, parallel-group study)

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 25 Sep 2017

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

11 Sep 2017 Primary endpoint (Decrease from baseline in the pain score and visual analogue scale at the end of the treatment) has been met, as per the results published in the Fertility and Sterility.
11 Sep 2017 Results assessing efficacy and safety of dienogest, published in the Fertility and Sterility.
24 Nov 2015 Status changed from not yet recruiting to completed.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com